Draxxin Tulathromycin is a novel macrolide from a new subclass known as triamilides. From Pfizer, this medication has quickly secured its place as the first-line BRD (bovine respiratory disease) treatment. It is incredibly impressive in treating this disease, even in high-risk cattle.
Key Benefits: Draxxin is a parenterally-injected, ready-to-use, sterile preparation that uses Tulathromycin, a semi-synthetic Triamilide Macrolide antibiotic.
Formulated For: For swine, beef cattle, and dairy calves use only
How is Medication Given? For swine, inject an intramuscular dose at a rate of 2.5 mg per kg of body weight (0.25 mL per 22 pounds), never exceeding a dose of 2.5 mL in a single injection site. Dosing recommendations are as follows:
For cattle, inject an intramuscular dose at a rate of 2.5 mg per kg of body weight (1.1 mL per 100 pounds), never exceeding a dose of 10 mL in a single injection site. Dosing recommendations are as follows:
What Results Can I Expect? Draxxin is exceptionally effective against bovine respiratory disease (BRD). A single dose delivers convenient, complete treatment. It is effective in treating the three main BRD-causing pathogens.
What Form Does Medication Come In? Injectable
Dose and Administration: Sold in 50, 100, 250, and 500 mL vials.
Possible Side Effects: Transient head-shaking occurred in certain treated animals. Field studies reported 2 instances of hypersalivation in calves. One of those two calves also experienced trouble breathing (dyspnea), which may have been related to pneumonia.
Precautions: Only for use in animals. Never use in humans. Keep out of reach of children. Never use in a chicken or turkey.
Storage Recommendations: Keep at or below 77 degrees F (25 degrees C)
In Case of Overdose: Contact the nearest emergency pet clinic.